General Name ：Recombinant Human Interferon α1b Eyedrops

      Clinical Application:Treatment of ocular viral infection , such as herpes simplex keratitis, conjunctivitis, iridocyclitis, uveitis, and acute retinal necrosis, etc.

      Product Features:

1. The antiviral mechanism is different with nucleosides, no drug resistance observed ; still shows curative effects on patients with nucleoside drugs resistance

2. Shows synergistic effect when combined with nucleoside drugs, improving cure rate and recurrence

3. Less dosage and better security

4. Higher purity  and less endotoxin

5. Better stability and longer validity period with patented  formula

State Support:

The 11th five-year major drug discovery projects — “bio-major varieties of transformation projects“